Delivery Order SPE2DB22D3004-SPE2DB25FSC24
- Not listed
- The Defense Logistics Agency awarded a $1,228.56 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextrose, an antibiotic pharmaceutical product, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 29, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger federal contracting portfolio with the agency. This delivery order derives...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,373.84 for Cefazolin 1 GM vials on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $3,025.80 to AmerisourceBergen Drug Corp for the supply of Cefazolin 1 G/50 ML with dextroses. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of July 31, 2025. The award was made on July 30, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $2,047.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Cefazolin 2G/50ML-Dextroses, an antibiotic medication in intravenous formulation. This non-set-aside competitive award is set for ultimate completion by August 25, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $6,142.80 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML-Dextroses on August 13, 2025, with an ultimate completion date of August 14, 2025. This non-set-aside contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $2,047.50 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML with Dextrose solution. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on February 20, 2025, with an ultimate completion date of February 21, 2025. The product will be delivered to Conshohocken, Pennsylvania, which serves as the vendor's corporate headquarters location. This delivery order is issued under...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,228.56, is a Firm Fixed Price Delivery Order for the supply of cefazolin 2 g/50 ml-dextrose medical products. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,550 units of the pharmaceutical product Cefazolin 2 g/50 mL-Dextroses. The contract, valued at $7,257.47, has an ultimate completion date of August 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,348.12 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564415606 Cefazolin 2 g/50 mL-Dextroses. This contract has an ultimate completion date of April 29, 2024 and is not set aside. Amerisourcebergen Drug Corp, through its Corporate Office Division, is a major pharmaceutical distributor for the U.S. federal government, particularly for the Department...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor. The $1,445.28 delivery order contract is for the supply of cefazolin 2 g/50 ml-dextrose, a critical antibiotic medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999, which enables the DLA to efficiently procure a comprehensive range of medical commodities...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSC24Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,228.56 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML in dextrose solution, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that supports military healthcare systems globally. As a critical pharmaceutical distributor, AmerisourceBergen supplies an extensive portfolio of medications and medical supplies to federal health systems, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare programs. The Cefazolin order represents a routine antibiotic procurement through DLA's established pharmaceutical supply chain, supporting ongoing medical supply needs for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/21/25 |